Thursday, October 27, 2016: 2:00 PM-3:30 PM
Room: La Nouvelle Orleans Ballroom
At the conclusion of this session, participants will be able to:
- discuss the evidence in support of treatment of staphylococcal osteomyelitis with oral antibiotics alone
- review the risk of HIV transmission to a sexual partner when the HIV viral load is undetectable due to effective ART
- review recent evidence for the role of asymptomatic carriers of Clostridium difficile in the epidemiology of CDI
Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists
Trainee, Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID
Patrick Joseph, MD, FIDSA, FSHEA, University of California, San Francisco
J Trees Ritter, DO, FIDSA, Central Coast Infectious Diseases Consultants
RESOLVED! Oral Antibiotics Are Appropriate Initial Therapy for Staphylococcal Osteomyelitis
Do HIV Viral Load Undetectable Males Need to Wear a Condom?
Should All Hospital Admissions be Screened for Clostridium difficile?
Maximum of 1.5 hours of AMA PRA Category 1 Credit™
ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE
J. T. Ritter,